Get the Stockscreener App
7.54
2.71%
-0.21
After Hours:
7.76
0.22
+2.92%
Vicarious Surgical Inc stock is traded at $7.54, with a volume of 3,739.
It is down -2.71% in the last 24 hours and down -12.53% over the past month.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
See More
Previous Close:
$7.75
Open:
$7.74
24h Volume:
3,739
Relative Volume:
0.19
Market Cap:
$39.81M
Revenue:
-
Net Income/Loss:
$-71.07M
P/E Ratio:
-15.39
EPS:
-0.49
Net Cash Flow:
$-63.98M
1W Performance:
+12.87%
1M Performance:
-12.53%
6M Performance:
-46.10%
1Y Performance:
-15.55%
1-Day Range:
$7.50
$7.8247
1-Week Range:
$6.89
$7.8681
52-Week Range:
$4.2701
$19.00
Vicarious Surgical Inc Stock (RBOT) Company Profile
Name
Vicarious Surgical Inc
Sector
Industry
Phone
(617) 868-1700
Address
78 FOURTH AVENUE, WALTHAM
Compare RBOT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
7.54 | 39.63M | 0 | -71.07M | -63.98M | -0.49 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-07-22 | Initiated | Credit Suisse | Outperform |
| Dec-07-21 | Initiated | Cowen | Outperform |
| Nov-05-21 | Initiated | Canaccord Genuity | Buy |
| Oct-18-21 | Initiated | BTIG Research | Buy |
| Oct-07-21 | Initiated | Piper Sandler | Overweight |
View All
Vicarious Surgical Inc Stock (RBOT) Latest News
Long Term Trading Analysis for (RBOT) - news.stocktradersdaily.com
Vicarious Surgical CTO Khalifa Sammy sells $4,912 in stock By Investing.com - Investing.com Nigeria
Vicarious Surgical CTO Khalifa Sammy sells $4,912 in stock - Investing.com
Critical Survey: Anteris Technologies Global (NASDAQ:AVR) and Vicarious Surgical (NYSE:RBOT) - Defense World
Vicarious Surgical’s Optimistic 2025 Outlook Amid Challenges - TipRanks
Vicarious Surgical Announces New Collaboration with UMass Memorial Medical Center - marketscreener.com
Vicarious Surgical Reports Q1 2025 Financial Results - TipRanks
Vicarious Surgical, UMass partner; SS Innovations targets de novo submission - MedTech Dive
Vicarious Surgical (RBOT) Partners with UMass Memorial to Advance Robotic Surgery | RBOT Stock News - GuruFocus
Vicarious Surgical (RBOT) Nears Clinical Milestone with Innovati - GuruFocus
Vicarious Surgical Inc. (NYSE:RBOT) Q1 2025 Earnings Call Transcript - Insider Monkey
Vicarious Surgical reports net loss of USD 15.3M in Q1 2025 - Medical Buyer
Earnings call transcript: Vicarious Surgical outlines Q1 2025 progress and challenges - Investing.com UK
Vicarious Surgical’s Strategic Advancements and Milestone Achievements Justify Buy Rating - TipRanks
Vicarious Surgical Announces New Collaboration With Umass Memorial Medical Center - marketscreener.com
Vicarious Surgical Reports First Quarter 2025 Financial Results - Eagle-Tribune
Vicarious Surgical (RBOT) to Release Quarterly Earnings on Monday - Defense World
(RBOT) Proactive Strategies - news.stocktradersdaily.com
Geode Capital Management LLC Buys 2,336 Shares of Vicarious Surgical Inc (NYSE:RBOT) - Defense World
Next-Gen Surgical Robotics Pioneer Vicarious Surgical Announces Q1 2025 Financial Results Date - Stock Titan
Vicarious Surgical to Report First Quarter 2025 Financial Results on May 12, 2025 - Bluefield Daily Telegraph
Vicarious Surgical (NYSE:RBOT) Stock Price Up 20% – Still a Buy? - Defense World
Vicarious Surgical enters consulting agreement with former CFO - MSN
(RBOT) Investment Analysis - news.stocktradersdaily.com
Vicarious Surgical receives continued listing standard notice - Medical Buyer
Vicarious Surgical receives continued listing standard notice from NYSE - MSN
Vicarious Surgical Faces NYSE Non-Compliance Notice - TipRanks
Vicarious Surgical Receives NYSE Noncompliance Notice - marketscreener.com
Vicarious Surgical Receives Continued Listing Standard Notice From The NYSE - marketscreener.com
NYSE Warning: Vicarious Surgical Must Boost Market Cap or Face Potential Delisting - Stock Titan
(RBOT) Long Term Investment Analysis - news.stocktradersdaily.com
RBOTVicarious Surgical Announces Reverse Stock Split - ADVFN
Vicarious Surgical President Randy Clark to Become Board Member - MPO-mag
Learn to Evaluate (RBOT) using the Charts - news.stocktradersdaily.com
Vicarious Surgical President Randy Clark to Transition to Board Member - citybiz
Vicarious Surgical president shifts to board role By Investing.com - Investing.com South Africa
Vicarious surgical CEO sells $1,275 in stock By Investing.com - Investing.com Australia
Vicarious Surgical Announces President Transition to Board Member Role - Ortho Spine News
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock By Investing.com - Investing.com Canada
Vicarious surgical CTO Khalifa Sammy sells $1,028 in stock - Investing.com
Vicarious surgical CEO sells $1,275 in stock - Investing.com
Vicarious Surgical president shifts to board role - Investing.com India
Vicarious Surgical announces president transition to board member role -March 24, 2025 at 04:31 pm EDT - MarketScreener
Strategic Leadership Shift: Vicarious Surgical President Elevates to Board Role After Key Achievements - Stock Titan
Vicarious Faces Another Delay for FDA Submission - MD+DI
Vicarious Surgical Inc (NYSE:RBOT) Sees Significant Growth in Short Interest - Defense World
Vicarious Surgical Inc Stock (RBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):